RECOPHARMA
Financiado
Removal and Recovery of Pharmaceutical Persistent Pollutants from Wastewater by...
Removal and Recovery of Pharmaceutical Persistent Pollutants from Wastewater by Selective Reagentless Process
Pharmaceutical drugs, characterized by their environmental persistence (e.g. cytostatic drugs [CDs]) have been detected in water bodies (drinking water, groundwater, surface water, and effluent wastewater) at concentrations up to...
Pharmaceutical drugs, characterized by their environmental persistence (e.g. cytostatic drugs [CDs]) have been detected in water bodies (drinking water, groundwater, surface water, and effluent wastewater) at concentrations up to μg/L level. Actual methods for the removal and degradation of CDs, including electrochemical, photochemical, and biological methods have been developed. However, these methods are expensive and sometimes inefficient for CDs complete removal from the treated water. Including the exploitation of previous results from EU funded projects, the goal of project RECOPHARMA is to design, develop, validate and demonstrate a novel process by sequential integration the potentials offered by Molecular Imprinted Polymers (MIPs), Reagentless Thermosorption (RTS), Nanocomposites Functional Materials, Advanced Oxidation Processes, for an effective treatment aiming the recovery of target recalcitrant CDs and degradation of corresponding transformation products or metabolites, working in a continuous operation mode. The suggested approach offers versatile, fast, highly efficient, and low-cost treatment for wastewaters.
RECOPHARMA brings together academic research centres and the private sector, with a long-term goal of designing and developing advanced water treatment technologies in the interest of the society and integrate them for demonstration following a circular economy approach. Through the scheduled secondments, the involved staff will perform the required R&I to demonstrate the technical and economic feasibility of the developed process, including the technical formation of specialists as a fundamental activity to project success. The secondments will also enhance the exchange of knowledge, best practices, know-how, innovations, experience, mutual cooperation and culture of work between different organizations, regions and countries through the partners’ well-established reputation as transfer hubs.
ver más
Duración del proyecto: 72 meses
Fecha Inicio: 2017-10-17
Fecha Fin: 2023-10-31
Fecha Fin: 2023-10-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2023-10-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
MSCA-RISE-2017:
Research and Innovation Staff Exchange
Cerrada
hace 7 años
Presupuesto
El presupuesto total del proyecto asciende a
896K€
Líder del proyecto
UNIVERSITAT AUTÒNOMA DE BARCELONA
No se ha especificado una descripción o un objeto social para esta compañía.
Total investigadores
1267
Total investigadores
1267
67.50K€ |
Participante